News
Zepbound is the preferred weight loss medicine vs. Wegovy and has consistently beaten the latter in U.S. weekly prescriptions ...
Shares of Eli Lilly (NYSE: LLY) sank after the drugmaker lowered its full-year profit outlook, and a potential headwind to ...
3hon MSN
Not long ago the largest company by market capitalization in Europe, the evolution of the weight loss medicine market has ...
7h
MarketBeat on MSNIs Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?CompanyOverview|NYSE:LLY] The world’s largest pharmaceutical stock, Eli Lilly and Company (NYSE: LLY), recently had its worst ...
Zepbound, Lilly’s obesity drug, has overtaken Novo’s equivalent, Wegovy, in the US and now commands over 50 per cent of the ...
Donald Trump has embarked on a tax-cutting and deregulation drive - Anna Moneymaker/) Donald Trump’s sweeping tax cuts risk ...
10h
Zacks.com on MSNFTAI Aviation (FTAI) Just Overtook the 20-Day Moving AverageFrom a technical perspective, FTAI Aviation (FTAI) is looking like an interesting pick, as it just reached a key level of support. FTAI recently overtook the 20-day moving average, and this suggests a ...
AstraZeneca has revealed that its top executive in China, Leon Wang, has been detained by Chinese authorities, after confirming he was under investigation last week. AZ also said four other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results